Cancer-Associated Inflammation
Cancer-linked inflammation shapes tumor behavior and host resilience. Measuring immune–blood cell balance quantifies this biology. At Superpower, we test NLR, PLR, SII, and SIRI to gauge systemic inflammatory load, immune surveillance, and prothrombotic signaling—neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, systemic immune-inflammation index, and systemic inflammation response index.
Kawasaki Disease
Biomarker testing helps detect and track the intense systemic inflammation of Kawasaki disease—a medium-vessel vasculitis that can affect the coronary arteries. At Superpower, we measure CRP and ESR (inflammatory activity), WBC count (immune activation), and Platelets (reactive thrombocytosis), to support early recognition and risk monitoring.
Rheumatoid Arthritis
Biomarker testing clarifies rheumatoid arthritis activity and systemic inflammation, guiding diagnosis and monitoring. ESR and CRP reflect acute-phase response; albumin shows protein reserve and negative acute-phase status; FAR and CAR integrate these signals into sensitive inflammation indices. At Superpower, we test ESR, CRP, Albumin, FAR, and CAR for rheumatoid arthritis.
